Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.63 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 51.15.
Market Cap
9.63T
Revenue
4.67T
Profits
188.26B
PE Ratio
51.15
Profit Margin
4.03%
Dividend Yield
0.38%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.14T | 3.49% | 2,970,842 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 625.03B | 2.19% | 7,775,147 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 510.84B | 2.26% | 5,175,548 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 376.33B | 3.04% | 6,889,030 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 365.88B | 3.25% | 9,954,106 | 66.57B |
| 6 | NVS | Novartis AG | 291.46B | 2.29% | 1,356,907 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 261.81B | 2.97% | 4,592,443 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 254.15B | 1.18% | 3,528,211 | 46.34B |
| 9 | AMGN | Amgen Inc. | 237.31B | 3.29% | 2,244,806 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 194.07B | 2.25% | 5,793,467 | 30.46B |
| 11 | ABT | Abbott Laboratories | 177.28B | -1.55% | 13,854,371 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 173.64B | 2.42% | 9,412,618 | 50.34B |
| 13 | PFE | Pfizer Inc. | 171.62B | 2.28% | 34,442,172 | 63.70B |
| 14 | DHR | Danaher Corporation | 157.64B | -0.08% | 9,523,569 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 154.74B | 1.11% | 3,597,153 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.44B | 2.53% | 1,230,676 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.99B | 4.84% | 11,907,963 | 49.19B |
| 18 | CVS | CVS Health Corporation | 121.18B | 2.23% | 7,070,375 | 412.65B |
| 19 | MCK | McKesson Corporation | 120.10B | 1.95% | 789,408 | 410.98B |
| 20 | SYK | Stryker Corporation | 116.76B | 2.17% | 3,170,300 | 25.84B |
| 21 | MDT | Medtronic plc | 115.84B | 2.00% | 15,143,015 | 37.54B |
| 22 | HCA | HCA Healthcare, Inc. | 100.84B | 2.39% | 1,316,131 | 78.01B |
| 23 | GSK | GSK plc | 100.16B | 2.37% | 5,597,603 | 44.05B |
| 24 | SNY | Sanofi | 99.05B | 4.62% | 4,203,763 | 55.89B |
| 25 | MRNA | Moderna, Inc. | 96.65B | 6.69% | 16,856,761 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 95.46B | 2.31% | 1,546,712 | 201.11B |
| 27 | CI | The Cigna Group | 81.02B | 2.71% | 1,440,520 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 80.63B | 3.25% | 621,972 | 15.53B |
| 29 | BSX | Boston Scientific Corporation | 66.06B | 1.18% | 16,013,116 | 21.00B |
| 30 | COR | Cencora, Inc. | 65.51B | 0.96% | 916,876 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 63.71B | 2.40% | 2,907,340 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 59.64B | 1.94% | 1,909,494 | 254.25B |
| 33 | NTRA | Natera, Inc. | 58.51B | 1.63% | 980,891 | 2.71B |
| 34 | ARGX | argenx SE | 54.82B | 5.34% | 536,442 | 5.32B |
| 35 | BDX | Becton, Dickinson and Company | 52.79B | 1.60% | 1,082,233 | 22.48B |
| 36 | VEEV | Veeva Systems Inc. | 51.60B | 0.59% | 1,809,752 | 3.46B |
| 37 | HUM | Humana Inc. | 51.32B | 2.99% | 2,084,000 | 145.68B |
| 38 | EW | Edwards Lifesciences Corporation | 50.89B | 1.23% | 1,795,561 | 6.51B |
| 39 | A | Agilent Technologies, Inc. | 48.78B | 1.83% | 1,978,708 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 47.60B | -1.11% | 4,224,455 | 17.32B |
| 41 | MDLN | Medline Inc. | 46.62B | 0.77% | 9,602,921 | 29.94B |
| 42 | HLN | Haleon plc | 44.30B | 0.30% | 18,761,639 | 14.80B |
| 43 | IQV | IQVIA Holdings Inc. | 44.09B | 0.74% | 1,688,950 | 16.98B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 43.95B | 0.38% | 439,739 | 4.55B |
| 45 | ONC | BeOne Medicines AG | 43.72B | 3.87% | 408,183 | 6.13B |
| 46 | WAT | Waters Corporation | 43.51B | 1.97% | 776,787 | 4.64B |
| 47 | RVMD | Revolution Medicines, Inc. | 42.13B | 7.91% | 2,735,548 | - |
| 48 | ILMN | Illumina, Inc. | 40.46B | 2.01% | 1,584,262 | 4.49B |
| 49 | BIIB | Biogen Inc. | 35.92B | 4.12% | 1,492,157 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 35.79B | 3.29% | 2,489,430 | 2.54B |
| 51 | CNC | Centene Corporation | 34.98B | 3.18% | 3,394,013 | 180.30B |
| 52 | RMD | ResMed Inc. | 34.53B | 2.39% | 1,244,714 | 5.65B |
| 53 | ZTS | Zoetis Inc. | 33.07B | 0.57% | 3,741,688 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 32.74B | 0.51% | 239,730 | 4.13B |
| 55 | ALC | Alcon Inc. | 32.67B | 2.57% | 978,654 | 10.86B |
| 56 | DXCM | DexCom, Inc. | 32.35B | -0.28% | 2,392,897 | 4.97B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.72B | 0.67% | 2,259,995 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.87B | -1.11% | 1,458,009 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.36B | 1.27% | 569,964 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 26.21B | 1.35% | 591,765 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.17B | 0.94% | 1,104,176 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 25.39B | 1.96% | 800,262 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 25.22B | 0.63% | 3,654,251 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.76B | 1.98% | 443,276 | 3.15B |
| 65 | INCY | Incyte Corporation | 23.64B | 2.97% | 1,341,789 | 5.82B |
| 66 | GMAB | Genmab A/S | 23.37B | 1.48% | 3,780,311 | 4.13B |
| 67 | BNTX | BioNTech SE | 22.90B | 2.20% | 1,835,790 | 3.03B |
| 68 | STE | STERIS plc | 21.96B | 1.45% | 551,045 | 6.04B |
| 69 | THC | Tenet Healthcare Corporation | 21.93B | 2.23% | 462,060 | 21.81B |
| 70 | GH | Guardant Health, Inc. | 21.82B | 2.98% | 1,308,928 | 1.18B |
| 71 | VTRS | Viatris Inc. | 21.42B | 2.14% | 14,265,640 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.89B | 0.40% | 2,612,486 | 1.14B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.31B | 1.06% | 1,211,532 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 17.41B | 3.36% | 1,396,745 | 2.91B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.37B | 0.45% | 403,821 | 2.78B |
| 76 | EXEL | Exelixis, Inc. | 15.95B | 2.73% | 2,136,862 | 2.44B |
| 77 | ASND | Ascendis Pharma A/S | 15.39B | 1.90% | 394,722 | 1.20B |
| 78 | CRL | Charles River Laboratories International, Inc. | 15.06B | 5.14% | 1,273,503 | 4.00B |
| 79 | SOLV | Solventum Corporation | 14.71B | 1.58% | 804,534 | 8.31B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.43B | 3.66% | 1,257,649 | 3.37B |
| 81 | HALO | Halozyme Therapeutics, Inc. | 14.12B | 1.53% | 2,202,255 | 1.66B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 13.88B | 2.56% | 663,214 | 4.60B |
| 83 | ICLR | ICON Public Limited Company | 13.44B | 3.60% | 936,238 | 8.29B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.21B | -0.57% | 2,732,825 | 713.07M |
| 85 | BTSG | BrightSpring Health Services, Inc. | 13.00B | 1.84% | 1,476,857 | 14.37B |
| 86 | SMMT | Summit Therapeutics Inc. | 12.87B | 3.34% | 6,227,058 | - |
| 87 | PEN | Penumbra, Inc. | 12.78B | 0.60% | 368,803 | 1.50B |
| 88 | BAX | Baxter International Inc. | 12.67B | -1.92% | 12,183,586 | 11.47B |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.59B | 3.88% | 549,475 | 830.81M |
| 90 | SNN | Smith & Nephew plc | 12.18B | 1.66% | 807,243 | 6.30B |
| 91 | TEM | Tempus AI, Inc. | 12.04B | 3.75% | 4,992,872 | 1.43B |
| 92 | EHC | Encompass Health Corporation | 12.00B | -0.03% | 1,427,807 | 6.21B |
| 93 | FMS | Fresenius Medical Care AG | 11.75B | -2.42% | 6,206,250 | 22.19B |
| 94 | MOH | Molina Healthcare, Inc. | 11.45B | 4.53% | 1,021,725 | 42.47B |
| 95 | TECH | Bio-Techne Corporation | 11.38B | 0.12% | 3,210,399 | 1.22B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.34B | -3.36% | 8,247,153 | 5.02B |
| 97 | COO | The Cooper Companies, Inc. | 11.24B | 1.65% | 2,053,314 | 4.24B |
| 98 | AVTR | Avantor, Inc. | 11.24B | 2.03% | 9,148,365 | 6.56B |
| 99 | DVA | DaVita Inc. | 11.18B | -6.23% | 2,071,528 | 14.01B |
| 100 | UHS | Universal Health Services, Inc. | 10.94B | 1.82% | 340,556 | 18.11B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.93B | 3.24% | 3,474,611 | 3.41B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.91B | 1.38% | 4,233,446 | 3.50B |
| 103 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.80B | 4.57% | 407,947 | 1.28B |
| 104 | ALGN | Align Technology, Inc. | 10.69B | 1.00% | 910,909 | 4.14B |
| 105 | GMED | Globus Medical, Inc. | 10.60B | 4.38% | 1,545,413 | 3.14B |
| 106 | PCVX | Vaxcyte, Inc. | 10.42B | 4.00% | 1,948,485 | - |
| 107 | OSCR | Oscar Health, Inc. | 10.38B | 3.44% | 5,853,045 | 15.32B |
| 108 | GKOS | Glaukos Corporation | 10.22B | 3.88% | 613,796 | 612.84M |
| 109 | ENSG | The Ensign Group, Inc. | 10.17B | 1.70% | 328,934 | 5.49B |
| 110 | QGEN | Qiagen N.V. | 10.11B | 5.05% | 10,132,100 | 2.10B |
| 111 | RGEN | Repligen Corporation | 10.10B | 1.39% | 877,530 | 785.10M |
| 112 | PODD | Insulet Corporation | 9.89B | 0.48% | 1,131,470 | 3.05B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.63B | 1.61% | 195,436 | 440.48M |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 9.48B | 0.48% | 212,450 | 2.59B |
| 115 | HSIC | Henry Schein, Inc. | 9.44B | 0.85% | 1,231,690 | 13.60B |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.43B | 4.99% | 705,125 | 105.00M |
| 117 | TXG | 10x Genomics, Inc. | 9.31B | 2.25% | 2,860,882 | 616.91M |
| 118 | IBRX | ImmunityBio, Inc. | 9.29B | 4.16% | 14,110,326 | 165.79M |
| 119 | TWST | Twist Bioscience Corporation | 8.95B | 2.10% | 2,020,233 | 431.80M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.93B | 2.64% | 774,456 | 281.99M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.89B | 2.08% | 1,050,347 | 67.67M |
| 122 | CAI | Caris Life Sciences, Inc. | 8.79B | 1.30% | 3,537,158 | 989.61M |
| 123 | HNGE | Hinge Health, Inc. | 8.68B | 3.41% | 4,093,913 | 720.06M |
| 124 | SYRE | Spyre Therapeutics, Inc. | 8.54B | 7.88% | 1,708,497 | - |
| 125 | BRKR | Bruker Corporation | 8.52B | 1.01% | 1,447,837 | 3.50B |
| 126 | AXSM | Axsome Therapeutics, Inc. | 8.36B | 2.42% | 653,794 | 776.57M |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.32B | 2.95% | 1,742,402 | 669.50M |
| 128 | ABVX | ABIVAX Société Anonyme | 8.15B | 5.83% | 1,604,442 | 5.33M |
| 129 | ATR | AptarGroup, Inc. | 8.00B | 0.91% | 356,886 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.99B | 3.79% | 560,278 | 1.36B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.73B | 2.31% | 1,057,747 | 799.54M |
| 132 | PACS | PACS Group, Inc. | 7.56B | 4.08% | 813,635 | 5.55B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.54B | 2.30% | 2,486,649 | 874.09M |
| 134 | ALKS | Alkermes plc | 7.40B | 2.65% | 2,201,607 | 1.67B |
| 135 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | 1.66% | 885,843 | 7.46M |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 6.91B | 2.48% | 6,819,410 | 3.12B |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.82B | 3.77% | 10,550,808 | 2.58B |
| 138 | GRFS | Grifols, S.A. | 6.80B | -1.31% | 369,080 | 8.48B |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 6.73B | 4.57% | 9,754,900 | 324.97M |
| 140 | CHE | Chemed Corporation | 6.72B | 1.53% | 114,133 | 2.60B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.55B | 0.47% | 1,330,005 | 1.56B |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.49B | 4.64% | 1,236,599 | 840.85M |
| 143 | BLTE | Belite Bio, Inc | 6.22B | 4.83% | 209,728 | - |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.21B | 2.23% | 876,986 | 239.92M |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.11B | 3.07% | 171,729 | 290.54M |
| 146 | BLCO | Bausch + Lomb Corporation | 6.05B | 1.93% | 502,440 | 5.32B |
| 147 | DOCS | Doximity, Inc. | 5.94B | 6.04% | 4,356,060 | 655.57M |
| 148 | IMVT | Immunovant, Inc. | 5.91B | 3.51% | 1,448,983 | - |
| 149 | KOD | Kodiak Sciences Inc. | 5.83B | 1.77% | 865,823 | - |
| 150 | GRAL | GRAIL, Inc. | 5.57B | 1.84% | 738,536 | 165.26M |
| 151 | TFX | Teleflex Incorporated | 5.56B | 1.13% | 485,092 | 2.25B |
| 152 | WAY | Waystar Holding Corp. | 5.52B | 2.93% | 2,925,370 | 1.21B |
| 153 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52B | 3.44% | 633,301 | 618.07M |
| 154 | CGON | CG Oncology, Inc. | 5.49B | 3.29% | 766,679 | 6.23M |
| 155 | RDNT | RadNet, Inc. | 5.49B | 0.62% | 325,903 | 2.27B |
| 156 | MMSI | Merit Medical Systems, Inc. | 5.44B | 1.36% | 688,800 | 1.58B |
| 157 | COGT | Cogent Biosciences, Inc. | 5.42B | 4.10% | 2,311,785 | - |
| 158 | HAE | Haemonetics Corporation | 5.38B | -0.44% | 585,002 | 1.35B |
| 159 | MANE | Veradermics, Incorporated | 5.31B | 3.95% | 1,070,020 | - |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.25B | 2.26% | 964,655 | 1.01B |
| 161 | ORKA | Oruka Therapeutics, Inc. | 5.24B | 6.19% | 787,723 | - |
| 162 | STVN | Stevanato Group S.p.A. | 5.19B | -0.05% | 261,859 | 1.40B |
| 163 | RGC | Regencell Bioscience Holdings Limited | 5.18B | 3.98% | 387,274 | - |
| 164 | SHC | Sotera Health Company | 5.12B | 1.64% | 1,800,640 | 1.22B |
| 165 | ERAS | Erasca, Inc. | 5.11B | 7.34% | 4,199,413 | - |
| 166 | SRRK | Scholar Rock Holding Corporation | 5.04B | 2.78% | 1,614,182 | - |
| 167 | CON | Concentra Group Holdings Parent, Inc. | 4.94B | 1.52% | 1,314,738 | 2.29B |
| 168 | TVTX | Travere Therapeutics, Inc. | 4.93B | 3.58% | 2,057,649 | 591.33M |
| 169 | MMED | MiniMed Group, Inc. | 4.92B | -1.69% | 10,860,618 | 3.22B |
| 170 | BLLN | BillionToOne, Inc. | 4.88B | 2.44% | 398,646 | 397.41M |
| 171 | HTFL | HeartFlow, Inc. | 4.83B | 8.96% | 3,026,866 | 212.07M |
| 172 | CRSP | CRISPR Therapeutics AG | 4.82B | -0.32% | 2,156,292 | 13.39M |
| 173 | DFTX | Definium Therapeutics, Inc. | 4.71B | 6.43% | 1,746,260 | - |
| 174 | OPCH | Option Care Health, Inc. | 4.70B | 0.48% | 2,745,163 | 5.69B |
| 175 | LFST | LifeStance Health Group, Inc. | 4.67B | 3.82% | 1,960,713 | 1.58B |
| 176 | DNTH | Dianthus Therapeutics, Inc. | 4.40B | 5.65% | 1,865,286 | 1.90M |
| 177 | LIVN | LivaNova PLC | 4.39B | 2.02% | 583,799 | 1.47B |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.32B | 4.83% | 2,171,190 | - |
| 179 | ITGR | Integer Holdings Corporation | 4.31B | -0.04% | 904,732 | 1.84B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.26B | 7.31% | 2,674,926 | 53.81M |
| 181 | ARQT | Arcutis Biotherapeutics, Inc. | 4.13B | 2.92% | 4,490,704 | 463.98M |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 4.10B | 2.66% | 1,925,378 | 1.33B |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.04B | 7.96% | 1,974,820 | 10.35M |
| 184 | ICUI | ICU Medical, Inc. | 4.03B | -0.10% | 160,203 | 2.16B |
| 185 | ADPT | Adaptive Biotechnologies Corporation | 3.90B | 1.96% | 1,245,345 | 308.08M |
| 186 | NHC | National HealthCare Corporation | 3.88B | 3.64% | 128,513 | 1.56B |
| 187 | ABCL | AbCellera Biologics Inc. | 3.79B | -1.84% | 4,263,275 | 66.17M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.76B | 3.91% | 304,952 | 890.79M |
| 189 | IRTC | iRhythm Holdings, Inc. | 3.75B | 3.88% | 499,155 | 825.34M |
| 190 | NVST | Envista Holdings Corporation | 3.69B | 1.59% | 4,859,090 | 2.86B |
| 191 | LEGN | Legend Biotech Corporation | 3.68B | 1.93% | 1,137,027 | 1.27B |
| 192 | PLSE | Pulse Biosciences, Inc. | 3.63B | 6.92% | 385,559 | 1.19M |
| 193 | OGN | Organon & Co. | 3.61B | 0.07% | 2,550,083 | 6.13B |
| 194 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.61B | 5.27% | 1,613,170 | -665.00K |
| 195 | VCYT | Veracyte, Inc. | 3.60B | 2.26% | 1,136,400 | 561.90M |
| 196 | CDNA | CareDx, Inc. | 3.58B | 3.16% | 1,561,952 | 458.09M |
| 197 | ACAD | Acadia Pharmaceuticals Inc. | 3.52B | 3.23% | 1,675,477 | 1.14B |
| 198 | XENE | Xenon Pharmaceuticals Inc. | 3.51B | 3.39% | 990,760 | 7.50M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.41B | 4.58% | 962,254 | 234.13M |
| 200 | PBLS | Parabilis Medicines, Inc. | 3.35B | 6.82% | 1,495,347 | 148.00K |
| 201 | LQDA | Liquidia Corporation | 3.25B | 6.50% | 3,996,486 | 450.91M |
| 202 | WRBY | Warby Parker Inc. | 3.17B | 2.52% | 2,845,326 | 911.61M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | 2.20% | 898,979 | 606.33M |
| 204 | VKTX | Viking Therapeutics, Inc. | 3.12B | 6.63% | 4,656,225 | - |
| 205 | IRON | Disc Medicine, Inc. | 3.05B | 0.70% | 2,205,540 | - |
| 206 | DYN | Dyne Therapeutics, Inc. | 3.04B | 6.83% | 3,405,265 | - |
| 207 | DNLI | Denali Therapeutics Inc. | 3.03B | 4.93% | 1,824,100 | 3.60M |
| 208 | RCUS | Arcus Biosciences, Inc. | 3.02B | 7.27% | 6,242,253 | 117.00M |
| 209 | ELVN | Enliven Therapeutics, Inc. | 3.02B | 6.59% | 1,938,204 | - |
| 210 | CELC | Celcuity Inc. | 2.94B | 5.04% | 2,382,928 | - |
| 211 | ATRC | AtriCure, Inc. | 2.93B | 3.87% | 446,376 | 569.62M |
| 212 | PRVA | Privia Health Group, Inc. | 2.93B | 2.18% | 823,965 | 2.36B |
| 213 | ACHC | Acadia Healthcare Company, Inc. | 2.93B | 4.14% | 1,380,633 | 3.37B |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.85B | 4.69% | 3,979,020 | 701.94M |
| 215 | ZLAB | Zai Lab Limited | 2.82B | 4.24% | 805,466 | 449.61M |
| 216 | AVAH | Aveanna Healthcare Holdings Inc. | 2.78B | 2.49% | 1,785,590 | 2.60B |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | 4.31% | 591,409 | 1.46B |
| 218 | TMDX | TransMedics Group, Inc. | 2.59B | 4.40% | 1,172,732 | 668.47M |
| 219 | HCM | HUTCHMED (China) Limited | 2.58B | 4.06% | 50,929 | 549.12M |
| 220 | MBX | MBX Biosciences, Inc. | 2.58B | 1.94% | 808,027 | - |
| 221 | NAMS | NewAmsterdam Pharma Company N.V. | 2.57B | 5.03% | 1,083,657 | 7.12M |
| 222 | NEOG | Neogen Corporation | 2.56B | 0.77% | 2,321,772 | 884.00M |
| 223 | CLOV | Clover Health Investments, Corp. | 2.55B | 8.11% | 3,503,489 | 2.48B |
| 224 | VRDN | Viridian Therapeutics, Inc. | 2.54B | 7.84% | 1,974,589 | 71.13M |
| 225 | ADMA | ADMA Biologics, Inc. | 2.52B | 1.45% | 2,896,317 | 512.28M |
| 226 | BEAM | Beam Therapeutics Inc. | 2.49B | 3.06% | 1,479,699 | 156.04M |
| 227 | PGEN | Precigen, Inc. | 2.45B | 2.55% | 6,115,574 | 85.72M |
| 228 | SLS | SELLAS Life Sciences Group, Inc. | 2.42B | 14.20% | 10,214,966 | - |
| 229 | BKD | Brookdale Senior Living Inc. | 2.40B | 2.13% | 3,242,160 | 2.93B |
| 230 | BHC | Bausch Health Companies Inc. | 2.40B | 1.58% | 2,030,425 | 10.85B |
| 231 | SUPN | Supernus Pharmaceuticals, Inc. | 2.40B | 3.49% | 1,240,345 | 830.44M |
| 232 | CLDX | Celldex Therapeutics, Inc. | 2.38B | 2.09% | 1,100,388 | 158.00K |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | -0.70% | 536,730 | 1.10B |
| 234 | UFPT | UFP Technologies, Inc. | 2.26B | -0.65% | 131,001 | 631.64M |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | 3.09% | 798,583 | 959.90M |
| 236 | PRGO | Perrigo Company plc | 2.24B | 0.50% | 1,765,280 | 4.14B |
| 237 | MD | Pediatrix Medical Group, Inc. | 2.23B | 2.86% | 707,862 | 1.95B |
| 238 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.52% | 593,682 | 311.51M |
| 239 | PGNY | Progyny, Inc. | 2.19B | 2.66% | 1,233,554 | 1.31B |
| 240 | RXRX | Recursion Pharmaceuticals, Inc. | 2.19B | 1.39% | 20,800,906 | 54.86M |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.19B | 4.99% | 1,518,815 | 98.34M |
| 242 | PHVS | Pharvaris N.V. | 2.17B | 3.80% | 1,027,710 | - |
| 243 | FTRE | Fortrea Holdings Inc. | 2.17B | 1.61% | 2,377,021 | 2.68B |
| 244 | VERA | Vera Therapeutics, Inc. | 2.17B | 3.94% | 1,189,446 | - |
| 245 | ADUS | Addus HomeCare Corporation | 2.16B | 2.49% | 138,916 | 1.48B |
| 246 | NEO | NeoGenomics, Inc. | 2.14B | 1.22% | 1,103,104 | 766.30M |
| 247 | AXGN | Axogen, Inc. | 2.12B | 2.64% | 974,616 | 251.17M |
| 248 | VCEL | Vericel Corporation | 2.08B | 0.52% | 475,254 | 306.30M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.08B | 4.96% | 1,177,992 | 1.14B |
| 250 | INSP | Inspire Medical Systems, Inc. | 2.06B | 1.70% | 1,052,257 | 898.74M |
| 251 | WGS | GeneDx Holdings Corp. | 2.05B | 3.70% | 927,761 | 454.43M |
| 252 | IMNM | Immunome, Inc. | 2.04B | 6.86% | 2,029,591 | 4.02M |
| 253 | XERS | Xeris Biopharma Holdings, Inc. | 2.03B | 1.64% | 2,901,130 | 335.41M |
| 254 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.03B | -1.61% | 8,455,132 | 940.61M |
| 255 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | 8.12% | 3,327,331 | 1.97B |
| 256 | SGRY | Surgery Partners, Inc. | 2.01B | 5.30% | 4,323,192 | 3.37B |
| 257 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | 0.28% | 1,074,929 | 6.13M |
| 258 | ASTH | Astrana Health, Inc. | 1.97B | 4.55% | 252,834 | 3.84B |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.95B | 3.22% | 293,686 | 1.13B |
| 260 | ALMR | Alamar Biosciences, Inc. | 1.95B | 7.07% | 681,532 | 100.42M |
| 261 | BFLY | Butterfly Network, Inc. | 1.95B | -2.14% | 3,477,192 | 112.14M |
| 262 | ZYME | Zymeworks Inc. | 1.91B | 5.36% | 3,130,337 | 37.13M |
| 263 | MLYS | Mineralys Therapeutics, Inc. | 1.91B | 3.15% | 1,000,796 | - |
| 264 | LMAT | LeMaitre Vascular, Inc. | 1.91B | 1.32% | 238,023 | 262.43M |
| 265 | NVAX | Novavax, Inc. | 1.89B | 5.64% | 6,526,341 | 413.80M |
| 266 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | 3.00% | 2,022,517 | 208.78M |
| 267 | XNCR | Xencor, Inc. | 1.85B | 7.55% | 884,200 | 104.97M |
| 268 | SEPN | Septerna, Inc. | 1.84B | 8.16% | 418,302 | 98.88M |
| 269 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 5.50% | 549,013 | 1.00M |
| 270 | NVCR | NovoCure Limited | 1.83B | 5.51% | 1,738,206 | 699.19M |
| 271 | TRVI | Trevi Therapeutics, Inc. | 1.83B | 7.82% | 1,827,815 | - |
| 272 | ALVO | Alvotech | 1.83B | 1.79% | 1,302,468 | 494.61M |
| 273 | ESTA | Establishment Labs Holdings Inc. | 1.82B | 4.69% | 359,533 | 245.82M |
| 274 | VIR | Vir Biotechnology, Inc. | 1.82B | 5.19% | 1,343,319 | 303.23M |
| 275 | MAZE | Maze Therapeutics, Inc. | 1.80B | 9.26% | 1,569,136 | 20.00M |
| 276 | PVLA | Palvella Therapeutics, Inc. | 1.79B | 0.78% | 266,371 | - |
| 277 | BHVN | Biohaven Ltd. | 1.78B | 4.05% | 1,527,914 | - |
| 278 | XRAY | DENTSPLY SIRONA Inc. | 1.77B | 5.34% | 6,141,542 | 3.64B |
| 279 | ALHC | Alignment Healthcare, Inc. | 1.77B | 1.31% | 3,417,055 | 4.58B |
| 280 | SDGR | Schrödinger, Inc. | 1.75B | 1.21% | 1,372,816 | 259.04M |
| 281 | STOK | Stoke Therapeutics, Inc. | 1.72B | 7.21% | 2,458,618 | 27.59M |
| 282 | URGN | UroGen Pharma Ltd. | 1.71B | 2.52% | 747,756 | 188.73M |
| 283 | ARDT | Ardent Health, Inc. | 1.71B | 3.68% | 343,081 | 6.41B |
| 284 | PSNL | Personalis, Inc. | 1.70B | 0.38% | 2,373,354 | 69.67M |
| 285 | KMTS | Kestra Medical Technologies, Ltd. | 1.68B | -3.71% | 601,219 | 106.73M |
| 286 | IMCR | Immunocore Holdings plc | 1.68B | 9.28% | 942,092 | 430.78M |
| 287 | ATEC | Alphatec Holdings, Inc. | 1.68B | 4.32% | 1,447,657 | 815.05M |
| 288 | NUVB | Nuvation Bio Inc. | 1.67B | 6.47% | 6,853,163 | 169.90M |
| 289 | KLRA | Kailera Therapeutics, Inc. | 1.67B | 12.77% | 1,579,956 | - |
| 290 | OMCL | Omnicell, Inc. | 1.66B | 1.90% | 444,759 | 1.25B |
| 291 | MESO | Mesoblast Limited | 1.66B | 3.85% | 245,569 | 120.25M |
| 292 | NTLA | Intellia Therapeutics, Inc. | 1.66B | 2.25% | 3,417,113 | 59.51M |
| 293 | GENB | Generate Biomedicines, Inc. | 1.66B | 2.71% | 522,700 | 26.48M |
| 294 | BRVE | Braveheart Bio, Inc. | 1.65B | 5.52% | 323,870 | - |
| 295 | CMPS | COMPASS Pathways plc | 1.65B | 7.11% | 3,351,010 | - |
| 296 | GPCR | Structure Therapeutics Inc. | 1.63B | 3.95% | 1,409,398 | - |
| 297 | SNDA | Sonida Senior Living, Inc. | 1.63B | 1.00% | 363,151 | 481.07M |
| 298 | AMN | AMN Healthcare Services, Inc. | 1.61B | 2.77% | 682,187 | 3.43B |
| 299 | COAG | Hemab Therapeutics Holdings, Inc. | 1.60B | 6.48% | 397,749 | - |
| 300 | QURE | uniQure N.V. | 1.58B | 2.32% | 1,414,729 | 18.67M |
| 301 | PAHC | Phibro Animal Health Corporation | 1.58B | -1.37% | 153,522 | 1.52B |
| 302 | RARE | Ultragenyx Pharmaceutical Inc. | 1.57B | 6.30% | 3,540,446 | 717.00M |
| 303 | AZTA | Azenta, Inc. | 1.57B | 2.55% | 754,545 | 613.81M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | 0.15% | 264,959 | 978.38M |
| 305 | ABSI | Absci Corporation | 1.56B | 6.21% | 2,826,011 | 1.56M |
| 306 | AGL | agilon health, inc. | 1.54B | 3.25% | 165,343 | 5.92B |
| 307 | INVA | Innoviva, Inc. | 1.54B | 0.95% | 507,563 | 440.00M |
| 308 | FRNM | Freenome, Inc. | 1.51B | 11.85% | 860,619 | 35.41M |
| 309 | CERT | Certara, Inc. | 1.49B | 3.54% | 2,784,408 | 421.75M |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.48B | 1.85% | 780,634 | 1.86B |
| 311 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | 13.70% | 1,033,330 | - |
| 312 | OCUL | Ocular Therapeutix, Inc. | 1.46B | 5.72% | 2,617,018 | 52.06M |
| 313 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.11% | 1,047,939 | 746.16M |
| 314 | PNTG | The Pennant Group, Inc. | 1.45B | 2.02% | 286,982 | 1.10B |
| 315 | ETON | Eton Pharmaceuticals, Inc. | 1.43B | 1.97% | 320,550 | 105.60M |
| 316 | AAPG | Ascentage Pharma Group International | 1.43B | 3.65% | 4,888 | 94.61M |
| 317 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 8.33% | 2,019,211 | - |
| 318 | CNMD | CONMED Corporation | 1.43B | 3.32% | 440,152 | 1.37B |
| 319 | KRSA | Korsana Biosciences, Inc. | 1.41B | -1.31% | 105,817 | - |
| 320 | RAPP | Rapport Therapeutics, Inc. | 1.41B | 2.69% | 8,055,414 | 20.00M |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.41B | 5.84% | 607,588 | - |
| 322 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 6.14% | 221,421 | 1.30M |
| 323 | NUTX | Nutex Health Inc. | 1.36B | 4.05% | 102,836 | 846.72M |
| 324 | ANAB | AnaptysBio, Inc. | 1.36B | -7.74% | 1,205,982 | 106.09M |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 4.31% | 10,925,838 | 5.49M |
| 326 | NKTR | Nektar Therapeutics | 1.34B | 7.04% | 1,057,590 | 54.59M |
| 327 | LBRX | LB Pharmaceuticals Inc | 1.32B | 5.64% | 388,414 | - |
| 328 | GHRS | GH Research PLC | 1.32B | 4.84% | 277,232 | - |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.30B | 3.71% | 177,254 | 804.27M |
| 330 | DMRA | Damora Therapeutics, Inc. | 1.28B | 7.37% | 242,319 | - |
| 331 | KARD | Kardigan, Inc. | 1.26B | 4.40% | 768,711 | - |
| 332 | INNV | InnovAge Holding Corp. | 1.25B | 3.04% | 1,973,963 | 989.71M |
| 333 | OPK | OPKO Health, Inc. | 1.24B | 3.11% | 4,353,458 | 587.90M |
| 334 | BCAX | Bicara Therapeutics Inc. | 1.21B | 5.04% | 493,417 | - |
| 335 | CRON | Cronos Group Inc. | 1.21B | 0.92% | 885,461 | 179.09M |
| 336 | NBTX | Nanobiotix S.A. | 1.21B | 14.52% | 137,892 | 13.15M |
| 337 | SVRA | Savara Inc. | 1.21B | 2.81% | 4,421,630 | - |
| 338 | DRTS | Alpha Tau Medical Ltd. | 1.21B | 3.72% | 832,887 | - |
| 339 | GDRX | GoodRx Holdings, Inc. | 1.20B | 4.45% | 2,379,496 | 785.23M |
| 340 | OMER | Omeros Corporation | 1.20B | 1.22% | 725,295 | 38.42M |
| 341 | ENOV | Enovis Corporation | 1.19B | 4.13% | 1,185,244 | 2.30B |
| 342 | OMDA | Omada Health, Inc. | 1.18B | 7.09% | 1,222,521 | 309.76M |
| 343 | SNDX | Syndax Pharmaceuticals, Inc. | 1.18B | 1.22% | 3,912,321 | 252.25M |
| 344 | SLN | Silence Therapeutics plc | 1.18B | 0.15% | 13,910,650 | 615.00K |
| 345 | BVS | Bioventus Inc. | 1.17B | 3.41% | 331,267 | 581.85M |
| 346 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 0.85% | 1,586,980 | 1.04B |
| 347 | VSTM | Verastem, Inc. | 1.13B | 8.35% | 3,964,602 | 87.53M |
| 348 | TDOC | Teladoc Health, Inc. | 1.13B | 8.38% | 4,783,007 | 2.49B |
| 349 | IRMD | IRADIMED CORPORATION | 1.13B | 0.64% | 82,996 | 86.34M |
| 350 | VOR | Vor Biopharma Inc. | 1.13B | 5.49% | 795,983 | - |
| 351 | AORT | Artivion, Inc. | 1.13B | 3.64% | 631,120 | 471.47M |
| 352 | STAA | STAAR Surgical Company | 1.12B | 2.01% | 614,598 | 339.59M |
| 353 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.10B | -0.77% | 361,336 | 730.02M |
| 354 | AVLN | Avalyn Pharma Inc. | 1.09B | 5.57% | 217,517 | - |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.08B | 2.95% | 985,321 | 337.34M |
| 356 | REPL | Replimune Group, Inc. | 1.08B | 3.35% | 1,388,896 | - |
| 357 | CBLL | CeriBell, Inc. | 1.06B | 6.46% | 593,243 | 101.96M |
| 358 | HROW | Harrow, Inc. | 1.05B | 1.41% | 526,970 | 275.59M |
| 359 | JANX | Janux Therapeutics, Inc. | 1.05B | 2.75% | 869,443 | 24.00M |
| 360 | AHG | Akso Health Group | 1.05B | -7.77% | 7,685 | 13.83M |
| 361 | IART | Integra LifeSciences Holdings Corporation | 1.04B | -0.89% | 1,307,767 | 1.65B |
| 362 | CTY | City Therapeutics, Inc. | 1.04B | -2.94% | 632,844 | 14.34M |
| 363 | HSTM | HealthStream, Inc. | 1.03B | 1.38% | 152,920 | 321.12M |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.03B | 8.38% | 143,155 | - |
| 365 | IMTX | Immatics N.V. | 1.03B | 6.52% | 1,487,247 | 47.65M |
| 366 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | -0.37% | 189,492 | 1.04B |
| 367 | CSTL | Castle Biosciences, Inc. | 1.01B | 3.05% | 272,491 | 357.28M |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 1.01B | 6.64% | 147,782 | - |
| 369 | MNKD | MannKind Corporation | 996.78M | 0.32% | 2,170,259 | 393.63M |
| 370 | QDEL | QuidelOrtho Corporation | 974.46M | 11.36% | 2,624,526 | 2.67B |
| 371 | GLUE | Monte Rosa Therapeutics, Inc. | 969.16M | 6.57% | 1,865,616 | 28.73M |
| 372 | ANRO | Alto Neuroscience, Inc. | 957.90M | 6.97% | 869,407 | - |
| 373 | MGTX | MeiraGTx Holdings plc | 957.55M | 5.50% | 755,861 | 397.50M |
| 374 | CGEM | Cullinan Therapeutics, Inc. | 954.38M | 6.08% | 694,005 | - |
| 375 | JBIO | Jade Biosciences, Inc. | 945.06M | 7.45% | 881,296 | - |
| 376 | BBNX | Beta Bionics, Inc. | 933.87M | 5.34% | 656,725 | 119.01M |
| 377 | AVBP | ArriVent BioPharma, Inc. | 929.45M | 5.07% | 817,835 | - |
| 378 | SIBN | SI-BONE, Inc. | 920.57M | 4.48% | 639,382 | 213.60M |
| 379 | ODTX | Odyssey Therapeutics, Inc. | 909.97M | 4.92% | 317,338 | 99.00K |
| 380 | RIGL | Rigel Pharmaceuticals, Inc. | 898.69M | 2.98% | 366,186 | 276.79M |
| 381 | AKTS | Aktis Oncology, Inc. | 894.36M | 6.42% | 343,482 | 10.06M |
| 382 | KURA | Kura Oncology, Inc. | 887.83M | 6.62% | 1,543,379 | 77.23M |
| 383 | MLTX | MoonLake Immunotherapeutics | 878.30M | 5.85% | 1,237,562 | - |
| 384 | SGP | SpyGlass Pharma, Inc. | 875.00M | 6.06% | 99,257 | - |
| 385 | ALMS | Alumis Inc. | 867.22M | 5.68% | 1,535,199 | 7.40M |
| 386 | CRVS | Corvus Pharmaceuticals, Inc. | 860.56M | 6.01% | 1,066,872 | - |
| 387 | ABUS | Arbutus Biopharma Corporation | 856.68M | 2.36% | 2,114,272 | 181.72M |
| 388 | SLBT | SL Science Holding Limited | 855.40M | -1.96% | 22,659 | 3.27M |
| 389 | OBX | Obsidian Therapeutics, Inc. | 818.49M | 10.97% | 410,907 | - |
| 390 | GMRS | GMR Solutions Inc. | 814.52M | 5.01% | 734,957 | 5.88B |
| 391 | AHCO | AdaptHealth Corp. | 813.80M | 3.74% | 2,243,141 | 3.36B |
| 392 | INMD | InMode Ltd. | 812.78M | 0.50% | 379,005 | 374.63M |
| 393 | ARDX | Ardelyx, Inc. | 799.89M | 3.88% | 3,964,188 | 450.89M |
| 394 | HELP | Helus Pharma Inc. | 799.28M | 2.34% | 2,365,697 | - |
| 395 | GERN | Geron Corporation | 796.67M | 3.33% | 3,564,917 | 204.56M |
| 396 | VREX | Varex Imaging Corporation | 775.52M | - | 675,073 | 865.00M |
| 397 | APMD | Apnimed, Inc. | 770.59M | 11.51% | 311,028 | 115.12M |
| 398 | IVA | Inventiva S.A. | 769.82M | 9.40% | 2,638,052 | 2.81M |
| 399 | IAM | Iambic Therapeutics, Inc. | 758.89M | -2.02% | 981,065 | 18.25M |
| 400 | COLL | Collegium Pharmaceutical, Inc. | 757.24M | 1.09% | 536,154 | 808.21M |
| 401 | PHR | Phreesia, Inc. | 747.95M | 6.83% | 1,001,736 | 507.79M |
| 402 | IMMX | Immix Biopharma, Inc. | 738.67M | 8.39% | 1,226,136 | - |
| 403 | ANNX | Annexon, Inc. | 726.09M | -4.49% | 6,370,008 | - |
| 404 | FDMT | 4D Molecular Therapeutics, Inc. | 723.70M | 6.59% | 725,369 | 92.01M |
| 405 | OABI | OmniAb, Inc. | 721.14M | 5.76% | 1,930,823 | 38.46M |
| 406 | SANA | Sana Biotechnology, Inc. | 706.49M | 2.61% | 3,524,827 | - |
| 407 | LXRX | Lexicon Pharmaceuticals, Inc. | 703.03M | 1.94% | 1,410,970 | 41.47M |
| 408 | PRME | Prime Medicine, Inc. | 697.38M | 2.35% | 3,688,228 | 4.07M |
| 409 | DSGN | Design Therapeutics, Inc. | 694.66M | 4.32% | 580,794 | - |
| 410 | CTKB | Cytek Biosciences, Inc. | 694.11M | 1.71% | 805,957 | 206.71M |
| 411 | SGMT | Sagimet Biosciences Inc. | 690.65M | 9.93% | 2,175,257 | - |
| 412 | SLDB | Solid Biosciences Inc. | 686.24M | 8.11% | 1,465,021 | - |
| 413 | ANL | Adlai Nortye Group Ltd. | 685.19M | 2.50% | 242,556 | 18.06M |
| 414 | AURA | Aura Biosciences, Inc. | 680.30M | 4.29% | 1,164,028 | - |
| 415 | PHAR | Pharming Group N.V. | 678.44M | 7.03% | 6,279 | 366.48M |
| 416 | STLN | Starling Oncology, Inc. | 675.70M | 2.63% | 1,097,352 | 587.24M |
| 417 | WVE | Wave Life Sciences, Inc. | 673.90M | 7.89% | 3,615,826 | 65.37M |
| 418 | NVCT | Nuvectis Pharma, Inc. | 670.85M | 8.71% | 148,772 | - |
| 419 | ACHV | Achieve Life Sciences, Inc. | 669.90M | -1.51% | 2,111,935 | - |
| 420 | DNA | Ginkgo Bioworks Holdings, Inc. | 663.98M | -2.09% | 2,487,282 | 132.42M |
| 421 | AVTX | Avalo Therapeutics, Inc. | 662.87M | 6.64% | 1,869,561 | 59.00K |
| 422 | CADL | Candel Therapeutics, Inc. | 661.12M | 5.24% | 1,126,151 | - |
| 423 | GYRE | Gyre Therapeutics, Inc. | 654.23M | 1.31% | 242,073 | 109.82M |
| 424 | ATTO | Attovia Therapeutics, Inc. | 640.94M | 1.08% | 448,437 | 1.80M |
| 425 | OLMA | Olema Pharmaceuticals, Inc. | 634.36M | 1.97% | 1,871,544 | - |
| 426 | ZVRA | Zevra Therapeutics, Inc. | 621.75M | 3.05% | 432,228 | 136.07M |
| 427 | CLYM | Climb Bio, Inc. | 620.31M | 11.00% | 1,369,064 | - |
| 428 | MDXG | MiMedx Group, Inc. | 615.11M | -3.65% | 1,633,204 | 355.17M |
| 429 | KIDS | OrthoPediatrics Corp. | 613.58M | 6.67% | 233,301 | 252.72M |
| 430 | AVR | Anteris Technologies Global Corp. | 613.23M | 1.78% | 2,830,308 | 2.24M |
| 431 | PACB | Pacific Biosciences of California, Inc. | 609.23M | 6.52% | 10,364,311 | 159.27M |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 599.82M | 1.97% | 1,641,387 | 389.32M |
| 433 | WEAV | Weave Communications, Inc. | 591.19M | -0.14% | 2,799,850 | 257.79M |
| 434 | CRMD | CorMedix Inc. | 590.04M | 2.57% | 971,648 | 462.25M |
| 435 | SOPH | SOPHiA GENETICS SA | 589.94M | 6.78% | 637,111 | 86.17M |
| 436 | STTK | Shattuck Labs, Inc. | 586.12M | 8.75% | 1,555,643 | 1.00M |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 580.63M | 4.28% | 724,282 | 239.66M |
| 438 | DBVT | DBV Technologies S.A. | 571.22M | 6.13% | 210,566 | 5.04M |
| 439 | CBIO | Crescent Biopharma, Inc. | 559.41M | 5.74% | 299,610 | 11.88M |
| 440 | FLGT | Fulgent Genetics, Inc. | 559.39M | 1.14% | 161,009 | 323.93M |
| 441 | DRUG | Bright Minds Biosciences Inc. | 556.44M | 2.56% | 94,681 | - |
| 442 | PBYI | Puma Biotechnology, Inc. | 555.43M | 5.39% | 364,915 | 231.24M |
| 443 | ACRS | Aclaris Therapeutics, Inc. | 554.94M | 8.33% | 3,499,166 | 8.22M |
| 444 | ETRA | Electra Therapeutics, Inc. | 552.98M | 2.32% | 177,717 | - |
| 445 | EVH | Evolent Health, Inc. | 550.60M | 8.71% | 1,179,568 | 2.10B |
| 446 | CTMX | CytomX Therapeutics, Inc. | 546.93M | 7.26% | 4,103,534 | 18.30M |
| 447 | EVO | Evotec SE | 543.57M | 4.23% | 85,673 | 819.47M |
| 448 | FTH | Faeth Therapeutics, Inc. | 537.22M | 6.94% | 805,987 | - |
| 449 | VALN | Valneva SE | 536.07M | 3.27% | 13,029 | 163.30M |
| 450 | TCMD | Tactile Systems Technology, Inc. | 532.78M | 3.48% | 215,300 | 350.31M |
| 451 | MYGN | Myriad Genetics, Inc. | 529.90M | 31.59% | 24,003,960 | 806.60M |
| 452 | ENTX | Entera Bio Ltd. | 525.25M | 2.72% | 791,916 | 42.00K |
| 453 | DCTH | Delcath Systems, Inc. | 512.15M | 2.71% | 294,232 | 95.42M |
| 454 | SSII | SS Innovations International, Inc. | 508.98M | 3.67% | 21,857 | 52.40M |
| 455 | AQST | Aquestive Therapeutics, Inc. | 508.32M | 5.74% | 2,260,211 | 54.09M |
| 456 | NGNE | Neurogene Inc. | 508.29M | 5.09% | 205,853 | 925.00K |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 458 | EPRX | Eupraxia Pharmaceuticals Inc. | 502.90M | 9.21% | 938,688 | - |
| 459 | ARVN | Arvinas, Inc. | 500.86M | 5.51% | 540,849 | 316.70M |
| 460 | MNPR | Monopar Therapeutics Inc. | 498.24M | 3.86% | 89,529 | - |
| 461 | ANGO | AngioDynamics, Inc. | 496.66M | 3.69% | 1,367,371 | 325.38M |
| 462 | RGNX | REGENXBIO Inc. | 488.50M | 3.50% | 1,315,113 | 174.48M |
| 463 | EOLS | Evolus, Inc. | 486.79M | 0.14% | 447,803 | 316.49M |
| 464 | BWAY | BrainsWay Ltd. | 478.04M | 0.33% | 74,400 | 60.70M |
| 465 | MASS | 908 Devices Inc. | 475.75M | 0.70% | 369,729 | 60.84M |
| 466 | SGHT | Sight Sciences, Inc. | 474.86M | 4.36% | 258,347 | 83.38M |
| 467 | DMAC | DiaMedica Therapeutics Inc. | 467.54M | 10.17% | 168,155 | - |
| 468 | CERS | Cerus Corporation | 465.52M | 4.05% | 1,480,035 | 221.55M |
| 469 | NPCE | NeuroPace, Inc. | 463.72M | 5.79% | 116,795 | 106.99M |
| 470 | OCS | Oculis Holding AG | 462.37M | 2.32% | 318,663 | 1.45M |
| 471 | OVID | Ovid Therapeutics Inc. | 460.90M | 8.76% | 3,668,556 | 1.58M |
| 472 | ALLO | Allogene Therapeutics, Inc. | 459.50M | 2.31% | 4,579,501 | 4.64M |
| 473 | MPLT | MapLight Therapeutics, Inc. | 457.94M | 3.00% | 355,012 | - |
| 474 | BLSM | BlossomHill Therapeutics, Inc. | 457.70M | 1.69% | 74,918 | - |
| 475 | NRC | NRC Health | 457.65M | 1.07% | 74,694 | 140.00M |
| 476 | KMDA | Kamada Ltd. | 453.92M | 3.15% | 110,628 | 191.85M |
| 477 | ALT | Altimmune, Inc. | 447.39M | 3.14% | 2,298,644 | 31.00K |
| 478 | TLRY | Tilray Brands, Inc. | 444.39M | - | 2,902,434 | 963.10M |
| 479 | EIKN | Eikon Therapeutics, Inc. | 443.07M | 6.23% | 336,536 | - |
| 480 | AUTL | Autolus Therapeutics plc | 441.83M | 4.40% | 2,636,841 | 117.39M |
| 481 | PRTA | Prothena Corporation plc | 436.36M | 0.24% | 528,976 | 54.53M |
| 482 | PROK | ProKidney Corp. | 435.34M | 3.23% | 1,391,805 | 818.00K |
| 483 | SENS | Senseonics Holdings, Inc. | 434.10M | 2.37% | 365,417 | 48.55M |
| 484 | ASMB | Assembly Biosciences, Inc. | 431.44M | 5.11% | 222,789 | 74.85M |
| 485 | AGMB | AgomAb Therapeutics NV | 429.93M | 6.08% | 35,303 | - |
| 486 | RCEL | AVITA Medical, Inc. | 426.79M | 5.02% | 421,899 | 75.63M |
| 487 | TECX | Tectonic Therapeutic, Inc. | 426.66M | 3.19% | 143,666 | - |
| 488 | SPRY | ARS Pharmaceuticals, Inc. | 426.63M | 1.42% | 1,541,686 | 116.93M |
| 489 | SRTA | Strata Critical Medical, Inc. | 415.35M | 3.41% | 580,726 | 255.98M |
| 490 | YDES | YD Bio Limited | 413.66M | -4.58% | 178,133 | 1.24M |
| 491 | AUNA | Auna S.A. | 401.89M | 0.93% | 181,624 | 1.37B |
| 492 | OFIX | Orthofix Medical Inc. | 401.22M | 2.71% | 335,288 | 833.19M |
| 493 | TKNO | Alpha Teknova, Inc. | 396.76M | 8.68% | 480,932 | 43.70M |
| 494 | EDIT | Editas Medicine, Inc. | 396.24M | 6.61% | 2,266,487 | 47.01M |
| 495 | INDP | Indaptus Therapeutics, Inc. | 394.40M | 8.42% | 218,414 | - |
| 496 | SI | Shoulder Innovations, Inc. | 389.73M | 2.58% | 67,590 | 60.06M |
| 497 | CCCC | C4 Therapeutics, Inc. | 388.76M | 9.34% | 3,689,396 | 35.04M |
| 498 | TRXB | TRex Bio, Inc. | 388.75M | -2.43% | 64,232 | - |
| 499 | RZLT | Rezolute, Inc. | 388.12M | - | 1,225,180 | - |
| 500 | CARL | Carlsmed, Inc. | 387.15M | 3.81% | 50,706 | 63.30M |